Provided by Tiger Trade Technology Pte. Ltd.

Alexander's

258.01
+0.20000.08%
Volume:32.01K
Turnover:8.25M
Market Cap:1.32B
PE:7.80
High:259.00
Open:258.65
Low:256.98
Close:257.81
52wk High:289.43
52wk Low:201.28
Shares:5.11M
Float Shares:2.35M
Volume Ratio:1.41
T/O Rate:1.36%
Dividend:18.00
Dividend Rate:6.97%
EPS(TTM):33.06
EPS(LYR):5.50
ROE:92.02%
ROA:3.04%
PB:5.89
PE(LYR):46.94

Loading ...

BRIEF-Alexander's Q1 Adjusted FFO Per Share USD 2.6

Reuters
·
May 04

Alexander’s Announces First Quarter Financial Results

THOMSON REUTERS
·
May 04

Alexander's Q1 Adjusted Ffo per Share USD 2.6

THOMSON REUTERS
·
May 04

Alexander's Q1 EPS USD 0.91

THOMSON REUTERS
·
May 04

Alexander's Q1 Adjusted Ffo USD 13.364 Million

THOMSON REUTERS
·
May 04

Earnings Flash (ALX) Alexander's Posts Q1 Non-GAAP FFO $2.60 a Share, vs. FactSet Est of $2.82

MT Newswires Live
·
May 04

Alexander's Q1 FY26 net income drops to $4.66 million; revenue slips to $53.41 million

Reuters
·
May 04

Alexander's Inc expected to post a share - Earnings Preview

Reuters
·
May 01

ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026

GlobeNewswire
·
Apr 30

Alexander's declares quarterly dividend of $4.5 per share

Reuters
·
Apr 29

Earning Preview: Alexander's Q1 revenue is expected to decrease by 3.06%, and institutional views are Neutral-to-Cautious

Earnings Agent
·
Apr 27

Alexander's publishes financial calendar update on upcoming quarterly results and call

Reuters
·
Apr 21

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

GlobeNewswire
·
Apr 18

ALX Oncology Names Jeff Knight Chief Development, Operating Officer

MT Newswires Live
·
Apr 13

Press Release: ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

Dow Jones
·
Apr 13

Alexander’s announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 08

Alexander's 731 Office One unit grants Bloomberg $57 million rent abatement at 731 Lexington Ave

Reuters
·
Apr 01

ALX Oncology CEO Makes Notable Move With Latest Stock Sale

TIPRANKS
·
Mar 24

ALX Oncology Initiated at Overweight by Wells Fargo

Dow Jones
·
Mar 19

Wells Fargo Initiates ALX Oncology at Overweight With $5 Price Target

MT Newswires Live
·
Mar 19